Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s11306-009-0159-1.

Title:
Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice | Metabolomics
Description:
Previous genetic and proteomic studies identified altered activity of various enzymes such as those of fatty acid metabolism and glycogen synthesis after a single toxic dose of valproic acid (VPA) in rats. In this study, we demonstrate the effect of VPA on metabolite synthesis flux rates and the possible use of abnormal 13C labeled glucose-derived metabolites in plasma or urine as early markers of toxicity. Female CD-1 mice were injected subcutaneously with saline or 600 mg/kg) VPA. Twelve hours later, the mice were injected with an intraperitoneal load of 1 g/kg [U-13C]-d-glucose. 13C isotopomers of glycogen glucose and RNA ribose in liver, kidney and brain tissue, as well as glucose disposal via cholesterol and glucose in the plasma and urine were determined. The levels of all of the positional 13C isotopomers of glucose were similar in plasma, suggesting that a single VPA dose does not disturb glucose absorption, uptake or hepatic glucose metabolism. Three-hour urine samples showed an increase in the injected tracer indicating a decreased glucose re-absorption via kidney tubules. 13C labeled glucose deposited as liver glycogen or as ribose of RNA were decreased by VPA treatment; incorporation of 13C via acetyl-CoA into plasma cholesterol was significantly lower at 60 min. The severe decreases in glucose-derived carbon flux into plasma and kidney-bound cholesterol, liver glycogen and RNA ribose synthesis, as well as decreased glucose re-absorption and an increased disposal via urine all serve as early flux markers of VPA-induced adverse metabolic effects in the host.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

glucose, vpa, plasma, tracer, liver, cholesterol, cas, article, google, scholar, urine, glycogen, pubmed, treatment, synthesis, labeled, control, acid, rna, analysis, min, metabolism, toxicity, ribose, mice, single, decreased, animals, isotopomer, journal, dose, isotopomers, mass, fractions, regression, ucdglucose, lee, valproic, brain, enrichment, study, metabolic, expression, treated, turnover, activity, fig, drug, early, injected,

Topics {✒️}

[u-13c6]-d-glucose tracer injected plasma tracer [u-13c6]-d-glucose [u-13c6]-d-glucose tracer [u-13c]-d-glucose tracer /kg [u-13c]-d-glucose glucose-derived 13c-labeled acetate stable low-birth-weight infants [u-13c6]-d-glucose liquid-based cytology media glucose-derived acetate enrichment 13c-labeled glucose showed tracer glucose-derived acetate 13c-labeled positional isotopomers hereditary hemochromatosis-related abnormalities [u-13c3]-dl-lactate sodium di-n-propylacetate lc/ms/ms characterization article download pdf glucose-derived carbon flux amp-dependent kinase signaling full size image 600 mg/kg body weight 13c labeled fractions vehicle treated animals virtually identical [u-13c]glucose acetyl-coa enrichment transfer rna-derived ribose glucose–cholesterol regression curves substrate product cross-talk 13c positional enrichment 13c labeled fraction cholesterol gc/ms analyses mass isotopomer study derived glucose fraction vpa inhibits glucose valproic acid treated 30 mg/ml hydroxylamine hydrochloride tracer substrate flow multi-age rat model tracer glucose substrate mass isotopomer analysis 13c labeled cholesterol control animals exhibited positional 13c isotopomers gene expression profiles 13c labeled carbons vpa treated animals vpa-treated animals tracer substrate study

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice
         description:Previous genetic and proteomic studies identified altered activity of various enzymes such as those of fatty acid metabolism and glycogen synthesis after a single toxic dose of valproic acid (VPA) in rats. In this study, we demonstrate the effect of VPA on metabolite synthesis flux rates and the possible use of abnormal 13C labeled glucose-derived metabolites in plasma or urine as early markers of toxicity. Female CD-1 mice were injected subcutaneously with saline or 600 mg/kg) VPA. Twelve hours later, the mice were injected with an intraperitoneal load of 1 g/kg [U-13C]-d-glucose. 13C isotopomers of glycogen glucose and RNA ribose in liver, kidney and brain tissue, as well as glucose disposal via cholesterol and glucose in the plasma and urine were determined. The levels of all of the positional 13C isotopomers of glucose were similar in plasma, suggesting that a single VPA dose does not disturb glucose absorption, uptake or hepatic glucose metabolism. Three-hour urine samples showed an increase in the injected tracer indicating a decreased glucose re-absorption via kidney tubules. 13C labeled glucose deposited as liver glycogen or as ribose of RNA were decreased by VPA treatment; incorporation of 13C via acetyl-CoA into plasma cholesterol was significantly lower at 60 min. The severe decreases in glucose-derived carbon flux into plasma and kidney-bound cholesterol, liver glycogen and RNA ribose synthesis, as well as decreased glucose re-absorption and an increased disposal via urine all serve as early flux markers of VPA-induced adverse metabolic effects in the host.
         datePublished:2009-03-31T00:00:00Z
         dateModified:2009-03-31T00:00:00Z
         pageStart:336
         pageEnd:345
         license:https://creativecommons.org/licenses/by-nc/2.0
         sameAs:https://doi.org/10.1007/s11306-009-0159-1
         keywords:
            Valproic acid
            Stable isotope-based dynamic metabolic profiling (SiDMAP)
            [U-13C6]-d-glucose
            Biochemistry
            general
            Molecular Medicine
            Cell Biology
            Developmental Biology
            Biomedicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig6_HTML.gif
         isPartOf:
            name:Metabolomics
            issn:
               1573-3890
               1573-3882
            volumeNumber:5
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Richard D. Beger
               affiliation:
                     name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
                     address:
                        name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Deborah K. Hansen
               affiliation:
                     name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
                     address:
                        name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laura K. Schnackenberg
               affiliation:
                     name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
                     address:
                        name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Brandie M. Cross
               affiliation:
                     name:SiDMAP, LLC.
                     address:
                        name:SiDMAP, LLC., Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Javad J. Fatollahi
               affiliation:
                     name:SiDMAP, LLC.
                     address:
                        name:SiDMAP, LLC., Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:F. Tracy Lagunero
               affiliation:
                     name:SiDMAP, LLC.
                     address:
                        name:SiDMAP, LLC., Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zoltan Sarnyai
               affiliation:
                     name:University of Cambridge
                     address:
                        name:Department of Pharmacology, University of Cambridge, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Laszlo G. Boros
               affiliation:
                     name:SiDMAP, LLC.
                     address:
                        name:SiDMAP, LLC., Los Angeles, USA
                        type:PostalAddress
                     type:Organization
                     name:University of California
                     address:
                        name:UCLA School of Medicine, University of California, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice
      description:Previous genetic and proteomic studies identified altered activity of various enzymes such as those of fatty acid metabolism and glycogen synthesis after a single toxic dose of valproic acid (VPA) in rats. In this study, we demonstrate the effect of VPA on metabolite synthesis flux rates and the possible use of abnormal 13C labeled glucose-derived metabolites in plasma or urine as early markers of toxicity. Female CD-1 mice were injected subcutaneously with saline or 600 mg/kg) VPA. Twelve hours later, the mice were injected with an intraperitoneal load of 1 g/kg [U-13C]-d-glucose. 13C isotopomers of glycogen glucose and RNA ribose in liver, kidney and brain tissue, as well as glucose disposal via cholesterol and glucose in the plasma and urine were determined. The levels of all of the positional 13C isotopomers of glucose were similar in plasma, suggesting that a single VPA dose does not disturb glucose absorption, uptake or hepatic glucose metabolism. Three-hour urine samples showed an increase in the injected tracer indicating a decreased glucose re-absorption via kidney tubules. 13C labeled glucose deposited as liver glycogen or as ribose of RNA were decreased by VPA treatment; incorporation of 13C via acetyl-CoA into plasma cholesterol was significantly lower at 60 min. The severe decreases in glucose-derived carbon flux into plasma and kidney-bound cholesterol, liver glycogen and RNA ribose synthesis, as well as decreased glucose re-absorption and an increased disposal via urine all serve as early flux markers of VPA-induced adverse metabolic effects in the host.
      datePublished:2009-03-31T00:00:00Z
      dateModified:2009-03-31T00:00:00Z
      pageStart:336
      pageEnd:345
      license:https://creativecommons.org/licenses/by-nc/2.0
      sameAs:https://doi.org/10.1007/s11306-009-0159-1
      keywords:
         Valproic acid
         Stable isotope-based dynamic metabolic profiling (SiDMAP)
         [U-13C6]-d-glucose
         Biochemistry
         general
         Molecular Medicine
         Cell Biology
         Developmental Biology
         Biomedicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11306-009-0159-1/MediaObjects/11306_2009_159_Fig6_HTML.gif
      isPartOf:
         name:Metabolomics
         issn:
            1573-3890
            1573-3882
         volumeNumber:5
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Richard D. Beger
            affiliation:
                  name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
                  address:
                     name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Deborah K. Hansen
            affiliation:
                  name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
                  address:
                     name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laura K. Schnackenberg
            affiliation:
                  name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
                  address:
                     name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Brandie M. Cross
            affiliation:
                  name:SiDMAP, LLC.
                  address:
                     name:SiDMAP, LLC., Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Javad J. Fatollahi
            affiliation:
                  name:SiDMAP, LLC.
                  address:
                     name:SiDMAP, LLC., Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:F. Tracy Lagunero
            affiliation:
                  name:SiDMAP, LLC.
                  address:
                     name:SiDMAP, LLC., Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zoltan Sarnyai
            affiliation:
                  name:University of Cambridge
                  address:
                     name:Department of Pharmacology, University of Cambridge, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Laszlo G. Boros
            affiliation:
                  name:SiDMAP, LLC.
                  address:
                     name:SiDMAP, LLC., Los Angeles, USA
                     type:PostalAddress
                  type:Organization
                  name:University of California
                  address:
                     name:UCLA School of Medicine, University of California, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Metabolomics
      issn:
         1573-3890
         1573-3882
      volumeNumber:5
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
      address:
         name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
         type:PostalAddress
      name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
      address:
         name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
         type:PostalAddress
      name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
      address:
         name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
         type:PostalAddress
      name:SiDMAP, LLC.
      address:
         name:SiDMAP, LLC., Los Angeles, USA
         type:PostalAddress
      name:SiDMAP, LLC.
      address:
         name:SiDMAP, LLC., Los Angeles, USA
         type:PostalAddress
      name:SiDMAP, LLC.
      address:
         name:SiDMAP, LLC., Los Angeles, USA
         type:PostalAddress
      name:University of Cambridge
      address:
         name:Department of Pharmacology, University of Cambridge, Cambridge, UK
         type:PostalAddress
      name:SiDMAP, LLC.
      address:
         name:SiDMAP, LLC., Los Angeles, USA
         type:PostalAddress
      name:University of California
      address:
         name:UCLA School of Medicine, University of California, Los Angeles, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Richard D. Beger
      affiliation:
            name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
            address:
               name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Deborah K. Hansen
      affiliation:
            name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
            address:
               name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
               type:PostalAddress
            type:Organization
      name:Laura K. Schnackenberg
      affiliation:
            name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration
            address:
               name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
               type:PostalAddress
            type:Organization
      name:Brandie M. Cross
      affiliation:
            name:SiDMAP, LLC.
            address:
               name:SiDMAP, LLC., Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Javad J. Fatollahi
      affiliation:
            name:SiDMAP, LLC.
            address:
               name:SiDMAP, LLC., Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:F. Tracy Lagunero
      affiliation:
            name:SiDMAP, LLC.
            address:
               name:SiDMAP, LLC., Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Zoltan Sarnyai
      affiliation:
            name:University of Cambridge
            address:
               name:Department of Pharmacology, University of Cambridge, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Laszlo G. Boros
      affiliation:
            name:SiDMAP, LLC.
            address:
               name:SiDMAP, LLC., Los Angeles, USA
               type:PostalAddress
            type:Organization
            name:University of California
            address:
               name:UCLA School of Medicine, University of California, Los Angeles, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
      name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
      name:National Center for Toxicological Research (NCTR), United States Food and Drug Administration, Jefferson, USA
      name:SiDMAP, LLC., Los Angeles, USA
      name:SiDMAP, LLC., Los Angeles, USA
      name:SiDMAP, LLC., Los Angeles, USA
      name:Department of Pharmacology, University of Cambridge, Cambridge, UK
      name:SiDMAP, LLC., Los Angeles, USA
      name:UCLA School of Medicine, University of California, Los Angeles, USA

External Links {🔗}(150)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Isotope
  • Prism.js

CDN Services {📦}

  • Crossref

5.19s.